| The effects of corporate social responsibility on organizational performance in the Iranian pharmaceutical industry: The mediating role of TQM G Mehralian, JA Nazari, L Zarei, HR Rasekh Journal of cleaner production 135, 689-698, 2016 | 178 | 2016 |
| The effect of risk communication on preventive and protective Behaviours during the COVID-19 outbreak: mediating role of risk perception ST Heydari, L Zarei, AK Sadati, N Moradi, M Akbari, G Mehralian, ... BMC public health 21, 1-11, 2021 | 141 | 2021 |
| Nursing experiences of COVID‐19 outbreak in Iran: A qualitative study A Kalateh Sadati, L Zarei, S Shahabi, ST Heydari, V Taheri, R Jiriaei, ... Nursing open 8 (1), 72-79, 2021 | 139 | 2021 |
| Mental health status during COVID-19 pandemic in Fars Province, Iran: timely measures A Mani, AR Estedlal, M Kamali, SZ Ghaemi, L Zarei, N Shokrpour, ... BMC Public Health 20, 1-11, 2020 | 25 | 2020 |
| Burnout among nurses during coronavirus disease 2019 outbreak in Shiraz M Kamali, AK Sadati, MR Khademi, S Ghahramani, L Zarei, SZ Ghaemi, ... Galen Medical Journal 9, e1956, 2020 | 20 | 2020 |
| Willingness to pay for one quality-adjusted life year in Iran N Moradi, A Rashidian, S Nosratnejad, A Olyaeemanesh, M Zanganeh, ... Cost Effectiveness and Resource Allocation 17, 1-10, 2019 | 20 | 2019 |
| Expectations of citizens from the government in response to COVID-19 pandemic: a cross-sectional study in Iran L Zarei, S Shahabi, AK Sadati, R Tabrizi, ST Heydari, KB Lankarani BMC public health 21, 1-10, 2021 | 19 | 2021 |
| Evaluation of the indicators of hospital information system M Amiresmaili, L Zarei, E Sheibani, A Arabpur Health Information Management 10 (129), 1-13, 2013 | 15 | 2013 |
| Public sphere attitudes towards the rumor sources of the COVID-19 pandemic: evidence from community perceptions in Iran M Banakar, AK Sadati, L Zarei, S Shahabi, ST Heydari, KB Lankarani BMC Public Health 21, 1-9, 2021 | 12 | 2021 |
| Recommendations to improve insurance coverage for physiotherapy services in Iran: a multi criteria decision-making approach S Shahabi, D Skempes, M Behzadifar, R Tabrizi, B Nazari, MK Ghanbari, ... Cost Effectiveness and Resource Allocation 19, 1-15, 2021 | 12 | 2021 |
| The common concerns regarding the COVID-19 outbreak in Iran: Explored findings from a qualitative study S Shahabi, AK Sadati, L Zarei, M Noroozi, R Tabrizi, ST Heydari, ... | 12 | 2020 |
| The worth of a quality-adjusted life-year in patients with diabetes: an investigation study using a willingness-to-pay method N Moradi, A Rashidian, S Nosratnejad, A Olyaeemanesh, M Zanganeh, ... PharmacoEconomics-open 3, 311-319, 2019 | 12 | 2019 |
| The prevalence and risk factors of death anxiety and fear of COVID‐19 in an Iranian community: A cross‐sectional study A Mani, R Fereidooni, M Salehi‐Marzijarani, A Ardekani, S Sasannia, ... Health science reports 5 (4), e706, 2022 | 11 | 2022 |
| Investigation the determinants of pharmaceutical expenditure share of GDP in Iran and selected OECD countries A Kadkhodamanesh, V Varahrami, L Zarei, F Peiravian, M Hadidi, ... Journal of Pharmaceutical Policy and Practice 14 (1), 82, 2021 | 11 | 2021 |
| An application of multi-criteria decision-making approach to sustainable drug shortages management: evidence from a developing country A Moosivand, M Rangchian, L Zarei, F Peiravian, G Mehralian, ... Journal of Pharmaceutical Health Care and Sciences 7, 1-11, 2021 | 10 | 2021 |
| Affordability of medication therapy in diabetic patients: a scenario-based assessment in Iran’s health system context L Zarei, P Peymani, N Moradi, M Kheirandish, M Mirjalili, M Zare International Journal of Health Policy and Management 11 (4), 443, 2022 | 9 | 2022 |
| An application of analytic network process model in supporting decision making to address pharmaceutical shortage L Zarei, N Moradi, F Peiravian, G Mehralian BMC health services research 20, 1-11, 2020 | 8 | 2020 |
| Does CSR matter in the pharmaceutical distribution industry? The balanced scorecard perspective G Mehralian, L Zarei, M Akhgari, M Peikanpour International Journal of Pharmaceutical and Healthcare Marketing 13 (2), 228-243, 2019 | 7 | 2019 |
| The scarce drugs allocation indicators in Iran: a Fuzzy Delphi Method based consensus L Zarei, F Peiravian, MS Pishvaee, B Aghababaei Iranian Journal of Pharmaceutical Research: IJPR 18 (2), 1126, 2019 | 7 | 2019 |
| Transparency in public pharmaceutical sector: the key informants’ perceptions from a developing country A Esfandiari, V Yazdi-Feyzabadi, L Zarei, A Rashidian, H Salari BMC Health Services Research 21, 1-18, 2021 | 6 | 2021 |
Kamran B LankaraniDistinguished Professor of Internal Medicine, HPRC,Shiraz University of Medical SciencesVerified email at sums.ac.ir
